This accredited three-day interprofessional oncology conference is designed to advance the knowledge, competence, and performance of a broad healthcare team involved in cancer care. Target participants include medical oncologists, hematologists, radiation oncologists, surgical oncologists, physician associates/assistants (PAs), advanced practice registered nurses (APRNs), oncology nurses, clinical pharmacists, pharmacy technicians, radiation therapists, and general practitioners in internal and family medicine. Residents and fellows in these specialties are also encouraged to attend.

The conference will provide an evidence-based review of current standards of care and recent advancements in the management of solid tumors and hematologic malignancies. Key topics will include breast, lung, gastrointestinal (GI), gynecologic, genitourinary (GU), head and neck cancers, melanoma, and hematologic malignancies such as multiple myeloma, chronic lymphocytic leukemia (CLL), and non-Hodgkin lymphoma. Special sessions will address therapy-related toxicities, symptom management, and strategies to mitigate treatment-related complications through team-based care.

Participants will gain a deeper understanding of personalized oncology, with a focus on molecular diagnostics, targeted therapy, immunotherapy, and novel agents including antiangiogenics and next-generation chemotherapeutics. Emerging data from national and international oncology congresses—including AACR, ASCO, SABC, ASH, ESMO, and WCLC—will be reviewed, highlighting translational applications for clinical practice.

The educational format promotes team communication, collaboration, and coordinated care planning. Attendees will participate in live Q&A panels with multidisciplinary faculty, enabling dynamic discussion of clinical scenarios and strategies to optimize patient-centered outcomes.